Zendesk Adheres to Highest Standards of Data Protection With European BCR Approval
Zendesk, Inc. (NYSE: ZEN) a leading provider of software for better customer relationships, today announced that it has completed the EU approval process with the Irish DPC (peer reviewed by both the UK Information Commissioner’s Office (ICO) and the Dutch Data Protection Authority (DPA)) for its global Binding Corporate Rules (BCRs) as data processor and controller. This significant regulatory approval validates Zendesk’s implementation of the highest possible standards for protecting personal data globally, covering both the personal data of its customers and its employees.
“We firmly believe in delivering certainty to our customers for the protection of their data. The approval of our BCRs is significant for us and demonstrates our ongoing commitment to protecting the privacy of personal data at Zendesk,” said John Geschke, general counsel and senior vice president of administration at Zendesk. “In addition to our BCRs, Zendesk is a certified signatory to EU-US Privacy Shield and at the request of its customers will enter into the Zendesk Data Processing Agreement, which includes EU model clauses.”
“This provides further confirmation that Zendesk is a global business that values security and data privacy at its core,” said John Crossan, vice president EMEA at Zendesk. “As a result of the Irish DPC’s approval of our BCRs, companies across Europe know when they deal with Zendesk, they are dealing with one of the most secure customer relationship software providers globally with the highest data protection standards available today.”
BCRs are internal company-specific data protection policies enabling a global business the ability to transfer personal data within the company (as a data controller) and to process personal data of its EEA customers on an intra-group basis anywhere in the world (as a data processor).
Approval is based on rigorous criteria set out by the European Data Protection Agencies and the process required a thorough review of Zendesk’s global data privacy compliance policies and procedures as required by the EU DPAs. Zendesk is one of only a few software companies in the world to have received approval for its BCRs; and just the second company ever to receive approval from the Irish DPC. It was supported throughout the BCR regulatory approval process by leading European law firm, Fieldfisher.
BCRs make it possible for multinational companies to standardise their practices relating to the protection of personal data by assuring an identical level of protection and security, benchmarked against rigorous European data protection standards, regardless of where the customer is based in the world. They demonstrate that data protection is integral to the way a company carries out its business and are validation that the company has the highest possible standard for dealing with data. This provides assurance for even the most privacy and security conscious companies around the world when working with Zendesk.
A Forrester report into EU data protection laws highlighted that implementing BCRs demonstrates additional data protection dedication and can ease data transfer concerns for EU decision-makers. A growing number of multinational companies believe that BCRs are an appropriate and practical mechanism for managing transborder flows of personal data.
Zendesk has more than 101,000 paid customer accounts globally across a range of industries. In the EMEA region, the company has over 35,000 paid customer accounts in EMEA growing at over 30 percent year over year to end March 2017 including John Lewis, Trustpilot, Lampiris and e-Boks.
In addition to the approval of its BCRs, Zendesk has achieved its SOC 2 Type II compliance. Zendesk also complies with ISO 27001:2013 and 27018:2014, the standard for protecting Personally Identifiable Information (PII) in the cloud, set forth by the International Standards Organisation. Also, Zendesk, Inc. has been approved to sell its cloud software services on the UK Government Digital Marketplace's 'G-Cloud 9' framework.
Zendesk builds software for better customer relationships. It empowers organizations to improve customer engagement and better understand their customers. More than 101,000 paid customer accounts in over 160 countries and territories use Zendesk products. Based in San Francisco, Zendesk has operations in the United States, Europe, Asia, Australia, and South America. Learn more at www.zendesk.com.
Source: Zendesk, Inc.
Andy Sommer, +44 7724419227
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13 | Tiedote
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21 | Tiedote
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38 | Tiedote
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00 | Tiedote
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 12:00 | Tiedote
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme